Volume 28, Issue 4 - Artificial intelligence and Digital Health

A primer on anonymisation

Author: Jackie Raskind

Abstract

Download the full article

References

1. PhUSE. Protection of Personal Data in Clinical Documents – A Model Approach. Available from: Available from: http://www.transceleratebiopharmainc.com /wp-content/uploads/2017/02/ Protection-of-Personal-Data-in-Clinical- Documents.pdf
2. PhUSE. De-identification and anonymization of individual patient data in clinical studies. A Model Approach. Available from: Available from: http://www.transceleratebiopharmainc.com /wp-content/uploads/2015/04/ TransCelerate-De-identification-and- Anonymization-of-Individual-Patient-Datain- Clinical-Studies-V2.0.pdf
3. EMA. External Guidance on the Implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use. 2018 [cited 30 Oct 2019] Available from: Available from: https://www.ema.europa.eu/en/documents /regulatory-procedural-guideline/externalguidance- implementation-europeanmedicines- agency-policy-publicationclinical- data_en-3.pdf
4. Health Canada. Guidance Document on Public Release of Clinical Information. 2019 [cited 30 Oct 2019]. Available from: Available from: https://www.canada.ca/en/health-canada/ services/drug-health-product-reviewapproval/ profile-public-release-clinicalinformation- guidance/document.html
5. Hrynaszkiewicz I, Norton ML, Vickers AJ, Altman DG. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. BMJ. 2010;340:c181.
6. EMA. Data anonymization – A key enabler for clinical data sharing. Workshop report. 2017 [cited 30 Oct 2019]. Available from: Available from: https://www.ema.europa.eu/en/documents /report/report-data-anonymisation-keyenabler- clinical-data-sharing_en.pdf
7. El Emam K, Dankar FK. Protecting privacy using k-anonymity. J Am Med Inform Assoc. 2008; -15(5):627–7.
8. Keerie C, Tuck C, Milne G, Eldridge S, Wright N, Lewis SC. Data sharing in clinical trials - practical guidance on anonymising trial datasets. Trials. 2018;19(1):25. Author